Stephane Budel is a partner at DeciBio Consulting with over 20 years of combined experience in life science business consulting, entrepreneurship and academic research. Dr. Budel specializes in the analysis of start-ups to large-cap companies with established to emerging technologies in the life science research tools and molecular diagnostics spaces. He has supported precision medicine clients facing a broad range of challenging business development issues, including R&D prioritization, go-to-market strategy and evaluation of disruptive technologies. Stephane specializes in the cutting edge of these markets, with a deep understanding of the technical and business potential of innovative technologies such as spatial omics and NGS.